CLINICAL ASPECTS OF WINTER SEASONAL AFFECTIVE DISORDER (SAD)
冬季季节性情感障碍 (SAD) 的临床表现
基本信息
- 批准号:5203777
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The clinical profile of seasonal affective disorder (SAD), a recurring
condition of winter depressions and summer remissions, which we first
described over a decade ago, has by now been widely co rroborated.
Likewise, light therapy, which we first found be an effective treatment
for SAD, has become a mainstream psychiatric treatment. We have
continued to explore aspects of the clinical profile of SAD patients
(PTS) by: a) evaluating cognitive functioning; b) surveying self-
reported sensitivity to environmental chemicals and comparing responses
to those of other patient groups and controls; c) surveying PTS'
subjective experience of our research; and, d) comparing light visor and
light box effectiveness in PTS previously treated effectively with light
therapy.
Seven PTS who had been treated with light therapy (light box) following
participation in another winter study, were randomly assigned to either
further treatment with the light box or treatment with the light visor
daily for one week each. Blind raters assessed mood with the Structured
Interview Guide for the Hamilton Depression Rating Scale-SAD Version
(SIGH-SAD). PTS were maintained on the duration of light therapy that
had previously been found to be helpful, usually less than one hour twice
a day. There was no difference in depressive symptoms following the week
of treatment with the light visor, as compared with the light box.
A second study evaluated PTS sensitivity to exposure to environmental
chemicals. A standardized, self-administered questionnaire was
administered to 46 PTS, 73 patients with chronic fatigue syndrome (CFS),
27 patients with obsessive compulsive disorder, 21 patients with
Addison's Disease, 19 patients with Cushing's Syndrome, and 39 controls.
PTS and patients with Addison's Disease and CFS, reported highest
sensitivities to exposure to various environmental chemicals, and to a
significantly greater degree than those in the other groups. In general,
women reported greater chemical sensitivity than did men.
A third study of 10 PTS and nine controls (CRTS), administered two
cognitive tests in winter and again in summer: the pattern recognition
task and the Stroop task. There were no differences between PTS and CRTS
on either of the tasks. For the Stroop test, however, PTS and CRTS
performed better in summer than in the winter.
In a final study of 32 PTS who had been through a winter protocol in the
Seasonal Studies Program we gave a semi-structured interview, inquiring
about their experiences as research subjects. All PTS reported that the
research program had helped them, citing education about their condition,
light therapy and favorable personal interactions with staff as the chief
beneficial aspects. Most reported at least some element of their
participation as problematic, especially time demands. Most PTS stated
that they would be willing to participate in future studies.
季节性情感障碍(SAD)的临床特征,
冬季萧条和夏季缓解的条件,我们首先
十多年前描述的,现在已经被广泛地证实。
同样的,光疗法,我们首先发现是一种有效的治疗方法,
已经成为一种主流的精神病治疗方法。 我们有
继续探索SAD患者的临床特征
(PTS)通过:a)评估认知功能; B)调查自我,
报告了对环境化学品的敏感性,
与其他患者组和对照组的情况相比; c)调查PTS'
我们研究的主观经验;以及,d)比较遮光板和
光箱在以前用光有效治疗的PTS中的有效性
疗法
7名PTS接受了以下光疗(灯箱)治疗
参加另一项冬季研究的人,被随机分配到
进一步用灯箱处理或用遮光板处理
每天一次,每次一周。 盲评者用结构化的
汉密尔顿抑郁量表SAD版访谈指南
(叹气-悲伤)。 在光治疗期间维持PTS,
以前被发现是有帮助的,通常不到一个小时的两次
一天 一周后的抑郁症状没有差异
与灯箱相比,使用遮光板的治疗效果更好。
第二项研究评估了PTS对环境暴露的敏感性。
化学品 一个标准化的,自我管理的问卷调查,
对46例PTS,73例慢性疲劳综合征(CFS)患者,
27例强迫症患者,21例
Addison病组、库欣综合征组19例、对照组39例。
PTS和Addison病和CFS患者,报告最高
暴露于各种环境化学品的敏感性,以及
显著高于其他组。 总的来说,
女性比男性对化学物质更敏感。
第三项研究包括10名PTS和9名对照(CRTS),
在冬季和夏季进行认知测试:模式识别
任务和Stroop任务。 PTS和CRTS之间无差异
任何一项任务。 然而,对于Stroop测试,PTS和CRTS
夏天比冬天表现得更好。
在对32名参加了冬季方案的PTS的最后一项研究中,
我们进行了一次半结构化的采访,询问
他们作为研究对象的经历所有临时秘书处都报告说,
研究项目帮助了他们,引用了关于他们病情的教育,
光疗法和良好的个人互动与工作人员作为主任
有利的方面。 大多数人至少报告了他们的一些元素,
参与是有问题的,尤其是时间要求。 大多数临时秘书处表示,
他们愿意参与未来的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
N E ROSENTHAL其他文献
N E ROSENTHAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('N E ROSENTHAL', 18)}}的其他基金
SEROTONERGIC ABNORMALITIES IN SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY
季节性情感障碍和光疗中的血清素异常
- 批准号:
6162924 - 财政年份:
- 资助金额:
-- - 项目类别:
NEUROBIOLOGY OF SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY
季节性情感障碍的神经生物学和光疗法
- 批准号:
6162940 - 财政年份:
- 资助金额:
-- - 项目类别:
NEUROBIOLOGY OF SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY
季节性情感障碍的神经生物学和光疗法
- 批准号:
3781365 - 财政年份:
- 资助金额:
-- - 项目类别:
NEUROBIOLOGY OF SEASONAL AFFECTIVE DISORDER AND LIGHT THERAPY
季节性情感障碍的神经生物学和光疗法
- 批准号:
3880883 - 财政年份:
- 资助金额:
-- - 项目类别:
ANTIDEPRESSANT EFFECTS OF LIGHT IN SEASONAL AFFECTIVE DISORDER AND NORMAL CONTROL
光对季节性情感障碍和正常控制的抗抑郁作用
- 批准号:
3880882 - 财政年份:
- 资助金额:
-- - 项目类别:
EFFECTS OF LIGHT INTERVENTIONS IN SEASONAL AFFECTIVE DISORDER
轻度干预对季节性情感障碍的影响
- 批准号:
4696479 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Molecular mechanisms of PKA mutations underlying Cushing's syndrome
库欣综合征 PKA 突变的分子机制
- 批准号:
9904116 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Molecular mechanisms of PKA mutations underlying Cushing's syndrome
库欣综合征 PKA 突变的分子机制
- 批准号:
9759521 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Molecular mechanisms of PKA mutations underlying Cushing's syndrome
库欣综合征 PKA 突变的分子机制
- 批准号:
10377830 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Steroid 11β-hydroxylase inhibitor for Cushing's Syndrome
类固醇 11β-羟化酶抑制剂治疗库欣综合征
- 批准号:
9465756 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Role of HSP90 and its co-chaperone FKBP51 in the pathogenesis of Cushing's syndrome
HSP90 及其共伴侣 FKBP51 在库欣综合征发病机制中的作用
- 批准号:
286003474 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Research Grants














{{item.name}}会员




